Kaba Samer 4
4 · ALIMERA SCIENCES INC · Filed Jan 2, 2020
Insider Transaction Report
Form 4
Kaba Samer
Chief Medical Officer
Transactions
- Award
Common Stock
2019-12-31$7.58/sh+93$705→ 5,672 total
Footnotes (1)
- [F1]These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2019.